KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 1 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $115,000 | -12.2% | 28,069 | 0.0% | 0.00% | – |
Q4 2017 | $131,000 | -34.2% | 28,069 | 0.0% | 0.00% | – |
Q3 2017 | $199,000 | -80.6% | 28,069 | -61.2% | 0.00% | -100.0% |
Q4 2014 | $1,024,000 | -10.9% | 72,379 | -13.4% | 0.00% | -33.3% |
Q3 2014 | $1,149,000 | -20.5% | 83,579 | -11.1% | 0.00% | -25.0% |
Q2 2014 | $1,445,000 | -12.5% | 93,979 | -3.0% | 0.00% | -20.0% |
Q1 2014 | $1,651,000 | +4.0% | 96,879 | -21.0% | 0.01% | 0.0% |
Q4 2013 | $1,587,000 | +28.2% | 122,579 | 0.0% | 0.01% | +25.0% |
Q3 2013 | $1,238,000 | +48.6% | 122,579 | +9.9% | 0.00% | +33.3% |
Q2 2013 | $833,000 | +664.2% | 111,579 | +168.9% | 0.00% | – |
Q4 2012 | $109,000 | – | 41,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Old West Investment Management, LLC | 1,068,719 | $3,633,000 | 1.50% |
Abrams Capital Management | 9,108,867 | $30,970,000 | 0.82% |
Baupost Group | 25,791,678 | $87,692,000 | 0.67% |
Bristol Advisors, LLC | 51,100 | $174,000 | 0.29% |
RICE HALL JAMES & ASSOCIATES, LLC | 2,228,059 | $7,575,000 | 0.27% |
NEXTHERA CAPITAL LP | 200,000 | $680,000 | 0.13% |
LINCOLN CAPITAL CORP | 37,280 | $127,000 | 0.10% |
Meridian Wealth Management, LLC | 49,600 | $169,000 | 0.07% |
Rubric Capital Management LP | 199,883 | $680,000 | 0.07% |
Virtus ETF Advisers LLC | 155,009 | $527,000 | 0.05% |